Synthesis and analgesic effects of new pyrrole derivatives of phencyclidine in mice

Abstract

Phencyclidine (1-(1-phenylcyclohexyl)piperidine, CAS 956-90-1, PCP, I) and many of its analogues have shown some pharmacological effects. In this study, new pyrrole derivatives of I (1-(1-phenylcyclo-hexyl) pyrrole, II and 1-[1-(4-methylphenyl)(cyclohexyl)]pyrrole, III) and their intermediates were synthesized and the acute and chronic pains were examined on mice using tail immersion (as a model of acute thermal pain) and formalin (as a model of acute and chronic chemical pain) tests and the results were compared with the PCP and control groups.

The results indicated that III generated higher analgesic effects in the tail immersion test compared to the PCP and control (dimethyl sulfoxide, DMSO) groups, demonstrating a marked and significant increase in tail immersion latency, but this effect was not observed for II in the dose of 1 mg/kg. The formalin test showed that III was effective in acute chemical pain (phase I, 0–5 min after injection), but was not effective for II at the same dosage compared to the PCP and control groups. Also chronic pain will be significantly attenuated by III but II was not effective as compared to the other groups.

It is concluded that substitution of the aromatic pyrrole ring instead of piperidine in the PCP molecule will not be effective alone in tail immersion and formalin tests but the addition of a methyl group (with high electron donating and dipole moments) on the phenyl group plus substitution of the aromatic pyrrole ring can be effective in acute and chronic pain compared to the PCP and control groups.

Key words

Acute and chronic pain - CAS 956-90-1 - Formalin test - Phencyclidine, pyrrole derivatives - Tail immersion test

• References

• 1 Moriarty RM, Enache LA, Zhao L, Gilardi R, Mattson MV et al Rigid phencyclidine analogues. Binding to the phencyclidine and _s1 receptors. J Med Chem. 1998; 41: 468-77
• 2 Johnson KM, Jones SM. Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential. Annu Rev Pharmacol Toxicol. 1990; 39: 707-50
• 3 Contreras PC, Rice KC, Jacobson AE, O'Donohue TL. Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions. Eur J Pharmacol. 1986; 121: 9-18
• 4 de Costa BR, Mattson MV, George C, Linders JTM. Synthesis, configuration and activity of isomeric 2-phenyl-2-(N-piperidinyl)-bicyclo[3.1.0]hexanes at phencyclidine and s binding sites. J Med Chem. 1992; 35: 4704-12
• 5 Ahmadi A, Mahmoudi A. Synthesis and biological properties of 2-hydroxy-1-[1-phenyltetralin]piperidine and some of its intermediates as derivatives of phencyclidine. Arzneimittelforschung. 2005; 55 (9) 528-32
• 6 Ahmadi A, Shafiezadeh M, Fathollahi Y. Synthesis with improved yield and study on the analgesic effect of 2-hydroxyphencyclidine. Arzneimittelforschung. 2005; 55: 172-6
• 7 Ahmadi A, Khalili M, Abbassi S, Javadi M, Mahmoudi A, Hajikhani R. Synthesis and study on analgesic effects of 1-[1-(4-methylphenyl)(cyclohexyl)]-4-piperidinol and 1-[1-(4-methoxyphenyl)(cyclohexyl)]-4-piperidinol as two new phencyclidine derivatives. Arzneimittelforschung. 2009; 59 (4) 202-6
• 8 Ahmadi A, Khalili M, Mihandoust F, Barghi L. Synthesis and determination of acute and chronic pain activities of l-[l-(3-methyphenyl)(tetralyl)]piperidine as a new derivative of phencyclidine via tail immersion and formalin tests. Arzneimittelforschung. 2009; 60 (1) 30-5
• 9 Johnson PY, Pan R, Quan Wen J, Halfman CJ. Synthesis of amine derivatives of phencyclidine. J Org Chem. 1981; 46: 2049-54
• 10 Wiley JL, Compton DR, Dong Dai, Lainton JAH, Phillips M, Huffman JW et al Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J Pharmacol Exp Ther. 1998; 285 (3) 995-1004
• 11 Micheli F, Di Fabio R, Cavanni P, Rimland JM, Capelli AM, Chiamulera C et al Synthesis and pharmacological characterisation of 2,4-Dicarboxy-pyrroles as selective non-Competitive mGluR1 antagonists. Bioorg Med Chem. 2003; 11 (2) 171-83
• 12 Geneste P, Kamenka JM, Dessapt P. Method for stereoselective production of substituted cyclohexylcyanhydrines. Bull Soc Chim Fr. 1980; II: 187-91
• 13 Maddox VH, Godefroi EF, Parcell RF. The synthesis of phencyclidine and other 1-arylcyclohexylamines. J Med Chem. 1965; 8: 230-5
• 14 Hamura H, Yoshida M, Shimizu K, Matsukura T, Suzuki H, Narita M et al Antinociceptive effect of the combination of pentazocine with morphine in the tail-immersion and scald-pain tests in rats. Jpn J Pharmacol. 2000; 83 (4) 286-92
• 15 Padi SSV, Kulkarni SK. Minocycline prevents the development of neuropathic pain, but not acute pain: Possible anti-inflammatory and antioxidant mechanisms. Eur J Pharmacol. 2008; 601: 79-87
• 16 Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977; 4 (2) 161-74
• 17 Nicholso KL, Balster RL. Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats. Psychopharmacology. 2003; 170: 215-24
• 18 Al-deeb OAA. Synthesis and analgesic activity of new phencyclidine derivatives. Arzneimittelforschung. 1994; 44 (10) 1141-4
• 19 Ahmadi A, Mahmoudi A. Synthesis with improved yield and study on analgesic effect of 2-methoxyphencyclidine. Arzneimittelforschung. 2006; 56 (5) 346-350
• 20 Kamenka JM, Hamon J, Vignon J inventors; Societe de conseils de recherché et d'applications scientifiques (S.C.RA.S) (FR), assignee. Phencyclidine derivatives, preparation method and pharmaceutical compositions containing same. United States patent US 6,342,511B1.2002.